Effect of empagliflozin versus linagliptin on body composition in Asian patients with type 2 diabetes treated with premixed insulin
Abstract Insulin therapy often increases body weight and leads to visceral fat accumulation. Progression in diabetes is also associated with accelerated loss of muscle mass. Little is known about body composition changes in type 2 diabetes mellitus (T2DM) patients on insulin therapy who use sodium–g...
Main Authors: | Yi-Hong Zeng, Sung-Chen Liu, Chun-Chuan Lee, Fang-Ju Sun, Jason J. Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-21486-9 |
Similar Items
-
Green quantitative methods for linagliptin and empagliflozin in dosage forms
by: Fraihat Safwan M.
Published: (2024-04-01) -
4.6 Effects of Combined Therapy of Empagliflozin and Linagliptin Versus Metformin and Insulin Glargine on Blood Pressure and Vascular Function in Patients with Type 2 Diabetes
by: Christian Ott, et al.
Published: (2020-02-01) -
Journey from EMPA-REG to CARMELINA to EMPEROR-Preserved: Empagliflozin/linagliptin in heart failure and diabetes
by: Sharvil S Gadve, et al.
Published: (2022-01-01) -
Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
by: Matthias Kern, et al.
Published: (2012-01-01) -
Analytical quality by design based on design space in reversed-phase-high performance liquid chromatography analysis for simultaneous estimation of metformin, linagliptin and empagliflozin
by: Aya A. Marie, et al.
Published: (2022-06-01)